Your browser doesn't support javascript.
loading
Reduced Susceptibility of Mycobacterium tuberculosis to Bedaquiline During Antituberculosis Treatment and Its Correlation With Clinical Outcomes in China.
Liu, Yuhong; Gao, Mengqiu; Du, Jian; Wang, Lu; Gao, Jingtao; Shu, Wei; Wang, Yufeng; Xue, Zhongtan; Li, Liang; Pang, Yu.
Afiliação
  • Liu Y; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P.R. China.
  • Gao M; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P.R. China.
  • Du J; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P.R. China.
  • Wang L; National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P.R. China.
  • Gao J; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P.R. China.
  • Shu W; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P.R. China.
  • Wang Y; Department of Laboratory Quality Control, Innovation Alliance on Tuberculosis Diagnosis and Treatment (Beijing), Beijing, P.R. China.
  • Xue Z; Department of Laboratory Quality Control, Innovation Alliance on Tuberculosis Diagnosis and Treatment (Beijing), Beijing, P.R. China.
  • Li L; Clinical Center on TB, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P.R. China.
  • Pang Y; National Clinical Laboratory on Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, P.R. China.
Clin Infect Dis ; 73(9): e3391-e3397, 2021 11 02.
Article em En | MEDLINE | ID: mdl-32667984

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Plantas_medicinales Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies País/Região como assunto: Asia Idioma: En Revista: Clin Infect Dis Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Plantas_medicinales Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos / Mycobacterium tuberculosis Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies País/Região como assunto: Asia Idioma: En Revista: Clin Infect Dis Ano de publicação: 2021 Tipo de documento: Article